Predictive Value of Positive Surgical Margins after Radical Prostatectomy for Lymph Node Metastasis in Locally Advanced Prostate Carcinoma
Adv Urol. 2012;2012: 618574; Otto W, Gerber P, Rößler W, Wieland WF, Denzinger S
A rare location of metastasis from prostate cancer: hydronephrosis associated with ureteral metastasis
Adv Urol. 2012;2012: 656023; Schneider S, Popp D, Denzinger S, Otto W
HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy--status 2012
Aktuelle Urol. 2012;43(5): 330-6; Baumunk D, Cash H, Ebbing J, Porsch M, Janitzky A, Wendler JJ, Liehr UB, Ganzer R, Blana A, Schostak M
Tumour registry and reality: differential diagnosis of testicular tumours in childhood: survey and personal experience
Aktuelle Urol. 2012;43(2): 104-11; Ebert AK, Neisser C, Rösch WH
Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic
Aktuelle Urol. 2012;43(3): 162-6; Otto W, Nowrotek A, Burger M, Wieland WF, Rößler W, Denzinger S
Body mass index has no impact on sperm quality but on reproductive hormones levels
Andrologia. 2012; M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer
Anticancer Res. 2012;32(8): 3479-83; Rogenhofer S, Ellinger J, Kahl P, Stoehr C, Hartmann A, Engehausen D, Wieland WF, Müller SC, Hofstädter F, Walter B
Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study
BJU Int. 2012;109(8): 1155-1161; Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder
BJU Int. 2012;110(6 Pt B): E222-7; Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis
BJU Int. 2012;110(5): 674-81; Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF
Prospective evaluation of interobserver variability of the hydronephrosis index and the renal resistive index as sonographic examination methods for the evaluation of acute hydronephrosis
BJU Int. 2012;110(8 Pt B): E350-6; Rud O, Moersler J, Peter J, Waliszewski P, Gilfrich C, Häuser H, Burger M, Fritsche HM, Wieland WF, Ahmed AM, Brookman-May S, May M
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy
BJU Int. 2012;110(2b): E7-E13; Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer
BMC Cancer. 2012;12(1): 459; Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
Br J Cancer. 2012;107(11): 1826-32; Xylinas E, Cha EK, Sun M, Rink M, Trinh QD, Novara G, Green DA, Pycha A, Fradet Y, Daneshmand S, Svatek RS, Fritsche HM, Kassouf W, Scherr DS, Faison T, Crivelli JJ, Tagawa ST, Zerbib M, Karakiewicz PI, Shariat SF
A patient with fibroepithelial polyp of the ureter-a rare condition mimicking malignancy: a case report
Case Rep Urol. 2012;2012: 901693; Brummeisl W, Fritsche HM, Huber E, Wieland WF, Ganzer R
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Eur J Surg Oncol. 2012;38(7): 637-42; Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
Eur Urol. 2012; Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)
Eur Urol. 2012; Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, members of the CORONA project and the SATURN project
Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84
Eur Urol. 2012;61(4): e31-2; author reply e33-4; Burger M, Otto W, Hartmann A
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
Eur Urol. 2012;61(4): 818-25; Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V
Anatomic study of periprostatic nerve distribution: immunohistochemical differentiation of parasympathetic and sympathetic nerve fibres
Eur Urol. 2012; Ganzer R, Stolzenburg JU, Wieland WF, Bründl J
Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder
Eur Urol. 2012;62(4): 662-70; Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Eur Urol. 2012;61(1): 58-64; Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery
Eur Urol. 2012;62(4): 677-84; Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF, Bladder Cancer Research Consortium (BCRC) , Upper Tract Urothelial Carcinoma Collaboration (UTUCC) , Bastian PJ, Bensalah K, Bolenz C, Chromecki TF, Dinney CP, Fernández M, Ficarra V, Fradet Y, Izawa JI, Kabbani W, Kikuchi E, Koppie TM, Lerner SP, Martinez-Salamanca JI, Matsumoto K, Montorsi F, Ng CK, Oya M, Patard JJ, Remzi M, Roscigno M, Sagalowsky AI, Schoenberg MP, Seitz C, Skinner E, Ströbel P, Tilki D, Tritschler S, Walton TJ, Weizer A, Wolf J, Wood CG, Zigeuner R
Aquaporin 3 protein expression in transitional cell carcinoma: a potential marker with regard to tumour progression and prognosis?
Eur Urol. 2012;61(3): 627-8; Rubenwolf PC, Denzinger S, Otto W
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment
Eur Urol. 2012;61(2): 237-42; Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Eur Urol. 2012; Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, for the Upper Tract Urothelial Carcinoma Collaboration
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder
Gend Med. 2012;9(6): 481-9; Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M
Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis
Hum Pathol. 2012; Gunia S, Erbersdobler A, Koch S, Otto W, Stabiano S, D Alterio C, Brookman-May S
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
Int J Cancer. 2012;130(3): 611-21; Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B
Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma
J Cancer Res Clin Oncol. 2012;138(2): 359-61; Stoehr CG, Stoehr R, Hartmann A, Hofstaedter F, Junker K, Blaszyk H, Wieland WF, Otto W, Denzinger S, Walter B
Sonographic diagnosis of a posttraumatic arteriocavernosal fistula resulting in high-flow priapism
J Clin Ultrasound. 2012;40(1): 60-2; Keck B, Lotter G, Wieland WF, Wullich B, Uder M, Engehausen DG, Fritsche HM
Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis
J Urol. 2012 Oct 24. Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF; French National Database on Upper Tract Tumors; Upper Tract Urothelial Carcinoma Collaboration.
Testicular tumors in patients with exstrophy-epispadias complex
J Urol. 2012;188(4): 1300-5; Ebert AK, Kliesch S, Neissner C, Reutter H, Rösch WH
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder
J Urol. 2012;187(4): 1210-4; May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M
Assisted Reproductive Techniques and Risk of Exstrophy-Epispadias Complex: A German Case-Control Study
J Urol. 2012; Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert AK
Transition of adolescents with the exstrophy-epispadias complex to adult medicine: influence of long-term outcome results on management
Klin Padiatr. 2012;224(7): 455-60; Ebert AK, Reutter H, Neissner C, Rösch W
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
Med Oncol. 2012;29(2): 799-805; Walter B, Schrettenbrunner I, Vogelhuber M, Grassinger J, Bross K, Wilke J, Suedhoff T, Berand A, Wieland WF, Rogenhofer S, Andreesen R, Reichle A
Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention
Neuromodulation. 2012; Denzinger S, Nowrotek A, Weingart P, Burger M, Wieland WF, Rößler W, Otto W
Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma
Pathobiology. 2012;79(3): 162-8; Stoehr C, Burger M, Stoehr R, Bertz S, Ruemmele P, Hofstaedter F, Denzinger S, Wieland WF, Hartmann A, Walter B
Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry
Prostate Cancer Prostatic Dis. 2012;15(3): 256-9; Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, Conti GN, Ganzer R, Pasticier G, Thuroff S, Ward JF
Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning broders' grading of penile squamous cell carcinomas
Urol Int. 2012; Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
Urol Oncol. 2012;30(5): 666-72; Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF
Focal prostate cancer therapy: Capabilities, limitations and prospects
Urologe A. 2012; Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M, Arbeitsgruppe für Fokale und Mikrotherapie
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
Virchows Arch. 2012; Fritsche HM, Aziz A, Eder F, Otto W, Denzinger S, Wieland WF, May M, Hofstädter F, Hartmann A, Burger M
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria
Virchows Arch. 2012;460(3): 343-52; Walter B, Hartmann A, Hofstädter F, Junker K, Moch H, Bertz S, Denzinger S, Otto W, Gajda M, Stoehr CG
Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study
World J Urol. 2012;30(1): 97-103; Brookman-May S, May M, Wieland WF, Lebentrau S, Gunia S, Koch S, Gilfrich C, Roigas J, Hoschke B, Burger M
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series
World J Urol. 2012; Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R, Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
World J Urol. 2012;30(6): 753-9; Chromecki TF, Mauermann J, Cha EK, Svatek RS, Fajkovic H, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Novara G, Fritsche HM, Ficarra V, Stief CG, Dinney CP, Skinner E, Pummer K, Fradet Y, Shariat SF
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma
World J Urol. 2012; Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF
Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting
World J Urol. 2012;30(2): 219-23; Ganzer R, Brandtner A, Wieland WF, Fritsche HM
Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy
World J Urol. 2012;30(6): 841-6; Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A
Gender-dependent cancer-specific survival following radical cystectomy
World J Urol. 2012;30(5): 707-13; May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M
First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival
World J Urol. 2012;30(6): 875-7; Otto W, Denzinger S, Wieland WF, Hartmann A
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World J Urol. 2012;30(6): 807-14; Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS
Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC)
World J Urol. 2012;30(3): 411-7; Schwalenberg T, Stolzenburg JU, Ho TP, Mallock T, Hartenstein S, Alexander H, Zimmermann G, Hohenfellner R, Denzinger S, Burger M, Horn LC, Neuhaus J
Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores
World J Urol. 2012; Walter B, Weiss T, Hofstädter F, Gaumann A, Hartmann A, Rogenhofer S, Ganzer R, Wach S, Engehausen D, Wieland WF, Blana A
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz@csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie@csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
